Haohai Bio-Tech shareholder fails to execute planned reduction

Shanghai Haohai Biological Technology Co., Ltd. announced that shareholder Lou Guoliang did not execute any share reduction during the planned period from December 4, 2024, to March 3, 2025. Lou Guoliang, holding 3.68% of the company's shares, had previously announced plans to reduce holdings by no more than 800,000 shares. The company has confirmed that the current decision was based on the shareholder's need for personal funds and on market conditions.